IBEX Limited (IBEX) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects strong financial performance with record-high revenue and EPS growth, positive guidance, and successful market expansion, particularly in India. The Q&A session confirms sustainable growth in key areas and a positive outlook on AI integration. Despite increased expenses, the share repurchase plan supports shareholder value. Overall, the positive financials and strategic moves outweigh the risks, suggesting a positive stock price movement.
Key Financial Performance
Revenue (FY 2025) $558.3 million, up 10% year-over-year. Growth driven by vertical growth in HealthTech (23%), Travel, Transportation and Logistics (14%), and Retail & E-commerce (13%), along with growth in digital acquisition business.
Revenue (Q4 FY 2025) $147.1 million, up 18.2% year-over-year. Growth driven by vertical growth in Retail & E-commerce (25%), HealthTech (19%), and Travel, Transportation and Logistics (10%), as well as growth in digital acquisition business.
Adjusted EBITDA (FY 2025) $72 million, up more than 10% year-over-year. Growth attributed to higher-margin offshore locations, digital acquisition business, and site optimization efforts.
Adjusted EPS (FY 2025) $2.75, up 31% year-over-year. Growth driven by higher revenue, strong operating performance, lower tax rate, and fewer diluted shares outstanding.
Adjusted Net Income (FY 2025) $43 million, up 12% year-over-year. Growth driven by revenue growth and gross margin expansion in higher-margin offshore regions.
Free Cash Flow (FY 2025) $27.3 million, up slightly from $27 million in the prior year. Growth driven by increased revenue and lower use of working capital, offset by higher capital expenditures.
Net Income (FY 2025) $36.9 million, up from $33.7 million in the prior year. Growth driven by revenue growth and gross margin expansion, offset by increased SG&A and net interest expense.
Capital Expenditures (FY 2025) $18 million, up from $9 million in the prior year. Increase driven by expansions to meet strong demand in high-margin regions.
Offshore Revenue (FY 2025) Increased 15% year-over-year, comprising 51% of total revenue. Growth driven by focus on higher-margin offshore delivery locations.
Digital and Omnichannel Revenue (Q4 FY 2025) 82% of total revenue, up from 77% in the prior year quarter, growing 25% year-over-year. Growth driven by focus on higher-margin services.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI agent solutions: IBEX has deployed AI agent solutions like chatbots and voice bots to handle less complex interactions, providing a seamless integrated solution from AI agent to human agent.
Geographic expansion: IBEX expanded into new markets like India and highly profitable offshore regions.
Revenue growth: Achieved record fiscal year revenue of $558.3 million, up 10% from the previous year, with Q4 revenues increasing by 18%.
Operational efficiencies: Deployed AI internally to improve operational team efficiency and effectiveness.
Offshore revenue growth: Offshore revenue grew 17% year-over-year, comprising 49% of total revenue.
Strategic shift to AI: Transitioned to BPO 3.0, focusing on delivering AI solutions to clients and creating a competitive advantage.
Client diversification: Largest client now accounts for less than 10% of revenue, indicating a well-diversified client portfolio.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
AI and CX Integration: The integration of AI and CX (Customer Experience) solutions is seen as a competitive advantage, but the market perceives it as a potential threat. This could lead to challenges in maintaining differentiation and staying ahead of competitors.
Geographic Expansion: Investments in new markets like India and offshore regions are critical for growth but come with risks such as regulatory hurdles, cultural integration, and operational challenges.
Client Concentration: While client diversification has improved, the top 25 clients still account for 79% of revenue, posing a risk if any major client reduces or terminates their engagement.
Fintech Vertical Decline: Revenue from the Fintech vertical has decreased, which could impact overall growth if not stabilized or compensated by other verticals.
Increased SG&A Expenses: Higher selling, general, and administrative expenses, including investments in technology and team expansion, could pressure margins if revenue growth slows.
Capital Expenditures: Increased capital expenditures for expansions and technology upgrades could strain cash flow if not matched by proportional revenue growth.
Economic and Market Conditions: The fluid market environment and economic uncertainties could impact revenue growth and operational stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for FY 2026: Revenue is expected to be in the range of $590 million to $610 million.
Adjusted EBITDA Guidance for FY 2026: Adjusted EBITDA is expected to be in the range of $75 million to $79 million.
Revenue Guidance for Q1 FY 2026: Revenue is expected to be in the range of $143 million to $146 million.
Adjusted EBITDA Guidance for Q1 FY 2026: Adjusted EBITDA is expected to be in the range of $17.5 million to $19 million.
Capital Expenditures for FY 2026: Capital expenditures are expected to remain in the range of $20 million to $25 million.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: During fiscal 2025, IBEX repurchased a total of 3.9 million shares, including 58,000 shares in the fourth quarter for $1.7 million. The total share repurchase for the year amounted to $77.2 million, which includes a $70 million TRGI share repurchase.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why was there a 5% sequential growth in Q4, which historically has been flat or down?
A:The growth was attributed to sustainable annuity-type business, winning market share in the embedded base due to exceptional operational performance, growth in new markets like India, and significant expansion with existing clients such as a major e-commerce company. Additionally, the digital acquisition business under Mike Darwal's leadership accelerated significantly, and the new logo team performed well. There were no client losses.
Q:Is the growth in the 'other' vertical, which was up over 100% year-over-year and $8 million sequentially, sustainable?
A:Yes, the growth in the 'other' vertical is sustainable and not a one-time occurrence. It is driven by market share expansion and operational excellence.
Q:What is the company's perspective on the impact of Generative AI (GenAI) on the business?
A:The company views GenAI as a net positive, following the normal cadence of automation seen over decades. They have moved from proof of concept to full-scale production implementations, learning a lot in the process. They emphasize the importance of owning the entire customer journey, integrating AI and human agents, and leveraging their leadership position and data to create growth opportunities.
Q:Review of Unclear Management Responses
A:None of the questions were avoided or lacked clarity. All responses were detailed and addressed the questions directly.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI CX
AI agent
AI team
BPO Today
BPO goal
CEO afternoon
CEO journey
CFO afternoon
CX solution
CX threat
Commission risk
Deputy CFO
Digital Deputy
EVP Investor
FY CEO
FY IBEX
FY market
FY player
FY revenue
IBEX EVP
IBEX brand
IBEX family
IBEX inflection
IBEX leader
IBEX result
IBEX return
IBEX stride
IPO ed
Ibex Digital
India
digit margin
leader AI
pillar
profile
technology analytics
trophy client
IBEX Transcript
IBEX Limited (IBEX) Q3 2026 Earnings Call Transcript
Positive5-6
The earnings call highlights strong financial performance with a 10% revenue increase, improved gross margins, and a 15% rise in net income. These positive financial metrics are complemented by a 20% increase in operating cash flow, indicating robust financial health. Although strategic initiatives and operational updates were not discussed, the financial strength and growth in key sectors like healthcare and technology suggest a positive outlook. The absence of negative sentiment in the Q&A further supports a positive sentiment rating.
IBEX Limited (IBEX) Q2 2026 Earnings Call Transcript
Positive2-6
The earnings report indicates strong financial performance with a 16.7% revenue increase, improved EBITDA, and EPS growth. Despite challenges in the telecommunications vertical and increased capital expenditures, the company shows promising growth in high-margin sectors like HealthTech and AI. The raised revenue and EBITDA guidance further support a positive sentiment. The share repurchase program adds to shareholder value. The Q&A session confirmed favorable business mix shifts and long-term margin improvement strategies. Overall, the outlook is positive, suggesting a stock price increase of 2% to 8% over the next two weeks.
IBEX Limited (IBEX) Q1 2026 Earnings Call Transcript
Positive11-7
The earnings call summary indicates strong financial performance with a 16.5% revenue increase and a 74.1% rise in adjusted EPS. The guidance was raised, and share repurchases were made, both positive indicators. Despite some risks like a decline in telecommunications and increased CapEx, the growth in other verticals and AI investments are promising. The Q&A session confirmed management's confidence in future growth. Overall, the sentiment is positive, suggesting a stock price increase of 2% to 8% over the next two weeks.
IBEX Limited (IBEX) Q4 2025 Earnings Call Transcript
Positive9-11
The earnings call reflects strong financial performance with record-high revenue and EPS growth, positive guidance, and successful market expansion, particularly in India. The Q&A session confirms sustainable growth in key areas and a positive outlook on AI integration. Despite increased expenses, the share repurchase plan supports shareholder value. Overall, the positive financials and strategic moves outweigh the risks, suggesting a positive stock price movement.
IBEX Slides
IBEX Q3 FY2026 slides: revenue beats forecast, guidance raised2026-05-06
IBEX Q2 2026 slides reveal record revenue, 46% EPS growth as HealthTech vertical surges2026-02-05
IBEX Q1 2026 slides: revenue jumps 16.5%, digital services drive growth2025-11-06
ibex Q4 2025 slides: Record revenue growth and strong margins drive optimistic outlook2025-09-11
IBEX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
